Evofem Biosciences, Inc. financial data

Symbol
EVFM on OTC
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 11 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12% % 3.5%
Quick Ratio 2.3% % 28%
Debt-to-equity -115% % 1.4%
Return On Equity -0.54% % -104%
Return On Assets 2.6% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 132,530,081 shares 17%
Common Stock, Shares, Outstanding 126,685,925 shares 12%
Entity Public Float $1,200,000 USD 33%
Common Stock, Value, Issued $13,000 USD 18%
Weighted Average Number of Shares Outstanding, Basic 123,657,915 shares 55%
Weighted Average Number of Shares Outstanding, Diluted 6,421,746,555 shares 7927%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $20,183,000 USD 4.2%
Research and Development Expense $1,845,000 USD -37%
Selling and Marketing Expense $9,682,000 USD 5.5%
General and Administrative Expense $7,393,000 USD -36%
Costs and Expenses $16,811,000 USD -38%
Operating Income (Loss) $3,372,000 USD
Nonoperating Income (Expense) $2,979,000 USD -152%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $393,000 USD
Income Tax Expense (Benefit) $4,000 USD 50%
Net Income (Loss) Attributable to Parent $391,000 USD
Earnings Per Share, Basic 0 USD/shares -60%
Earnings Per Share, Diluted 0 USD/shares -57%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $578,000 USD -22%
Accounts Receivable, after Allowance for Credit Loss, Current $12,480,000 USD 27%
Inventory, Net $1,129,000 USD -28%
Other Assets, Current $55,000 USD -69%
Assets, Current $15,284,000 USD 12%
Property, Plant and Equipment, Net $418,000 USD -8.7%
Operating Lease, Right-of-Use Asset $182,000 USD 104%
Other Assets, Noncurrent $42,000 USD 17%
Assets $20,274,000 USD -15%
Accounts Payable, Current $13,153,000 USD -19%
Employee-related Liabilities, Current $2,587,000 USD -26%
Accrued Liabilities, Current $1,292,000 USD -77%
Contract with Customer, Liability, Current $4,500,000 USD
Liabilities, Current $84,820,000 USD 5.4%
Operating Lease, Liability, Noncurrent $54,000 USD 671%
Liabilities $89,711,000 USD -0.61%
Accumulated Other Comprehensive Income (Loss), Net of Tax $8,818,000 USD -235%
Retained Earnings (Accumulated Deficit) $897,390,000 USD 0.03%
Stockholders' Equity Attributable to Parent $74,336,000 USD -4.3%
Liabilities and Equity $20,274,000 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $560,000 USD 355%
Net Cash Provided by (Used in) Financing Activities $135,000 USD
Net Cash Provided by (Used in) Investing Activities $57,000 USD -307%
Common Stock, Shares Authorized 3,000,000,000 shares 0%
Common Stock, Shares, Issued 126,685,925 shares 12%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $368,000 USD 238%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $578,000 USD -22%
Deferred Tax Assets, Valuation Allowance $145,277,000 USD -0.78%
Deferred Tax Assets, Gross $145,324,000 USD -0.77%
Operating Lease, Liability $182,000 USD 104%
Depreciation $6,000 USD -50%
Payments to Acquire Property, Plant, and Equipment $14,000 USD 367%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,797,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid $193,000 USD 110%
Property, Plant and Equipment, Gross $534,000 USD -54%
Operating Lease, Liability, Current $128,000 USD 56%
Lessee, Operating Lease, Liability, to be Paid, Year Two $60,000 USD 650%
Lessee, Operating Lease, Liability, to be Paid, Year One $133,000 USD 58%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,000 USD 267%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $3,043,000 USD 0%
Operating Lease, Payments $64,000 USD 0%
Additional Paid in Capital $831,859,000 USD 0.34%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $499,000 USD
Share-based Payment Arrangement, Expense $166,000 USD -80%
Interest Expense $577,000 USD 2.3%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%